YAP1 and alveolar soft part sarcoma: Moreover, ASPSCR1-TFE3 in alveolar soft part sarcomas and papillary renal cell carcinomas, and YAP1-TFE3 in epithelioid hemangioendotheliomas have been demonstrated [2].